Search
for

    Did you mean Post-Finasteride Syndrome?
    Glossary Post-Finasteride Syndrome

    condition with persistent side effects after stopping finasteride

    Post-Finasteride Syndrome (PFS) is a condition that some individuals experience after discontinuing the use of finasteride, a medication commonly prescribed for hair loss and benign prostatic hyperplasia. Symptoms can include persistent sexual dysfunction, depression, anxiety, and cognitive impairments, which may continue for months or even years after stopping the drug. The exact cause of PFS is not well understood, and it remains a topic of ongoing research and debate within the medical community.

    Related Terms

    Research

    5 / 496 results
      Post-Finasteride Syndrome: An Emerging Clinical Problem

      research Post-finasteride syndrome: An emerging clinical problem

      26 citations , December 2019 in “Neurobiology of Stress”
      This review discusses adverse effects of 5 alpha-reductase inhibitors, particularly persistent side effects such as post-finasteride syndrome, and highlights the need for further investigation.
      Post-Finasteride Syndrome

      research Post-finasteride syndrome

      11 citations , August 2019 in “BMJ”
      This article reviews ongoing concerns about the safety of 5α-reductase inhibitors like finasteride, highlighting the lack of long-term data on persistent depression and sexual side effects after drug discontinuation; no new clinical results are reported.

      research A comment on the post-finasteride syndrome

      11 citations , January 2018 in “International Journal of Trichology”
      This commentary reviews the post-Finasteride syndrome and argues that while the condition's validity is debated, comprehensive guidelines are needed to address related risks and treatment options; it reports no new clinical results.

    Community Join

    5 / 181 results

    Learn

    3 / 801 results

      learn Dutasteride

      Heavy duty finasteride that comes with higher risks
      • Dutasteride side effects: what the label and studies actually report The Avodart label reports impotence in 4.7% and decreased libido in 3.0% of men in the first six months (1.7% and 1.4% on placebo), with new reports falling after month six; those figures come from BPH trials in older men, and the hair-loss trials in younger men run only six months. The label and studies also flag a PSA drop of about half, a small rise in high-grade prostate cancer in one trial, an observational link to depression, and sexual effects that the label says may persist after stopping.

      learn Finasteride

      Frontline, gold standard treatment for combatting androgenic alopecia

      learn Saw Palmetto

      a natural and far less effective alternative to Finasteride